Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Saved in:
Bibliographic Details
Title: Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.
Authors: Carleton N; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Chang AC; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Chen F; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Dana Farber Cancer Institute, Boston, Massachusetts., Puhalla SL; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Foldi J; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Waltermire H; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Tin A; Natera, Inc. , San Carlos, California., Cowher MS; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Lupinacci K; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Diego EJ; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Sabih Q; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Johnson RR; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Malhotra M; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Laubenthal A; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Gorantla V; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Balic M; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Bhargava R; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Joy M; Translational Pathology Imaging Laboratory, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Freeman T; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Translational Pathology Imaging Laboratory, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; NSABP Foundation , Inc., NRG Oncology, Pittsburgh, Pennsylvania., Bridges C; Natera, Inc. , San Carlos, California., Kalashnikova E; Natera, Inc. , San Carlos, California., Rodriguez A; Natera, Inc. , San Carlos, California., Liu MC; Natera, Inc. , San Carlos, California., Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., McAuliffe PF; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Division of Breast Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jul 17; Vol. 32 (14), pp. 2957-2967.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-25-4079